Supplementary files: a topical non-steroidal anti-inflammatory cream
Description
Supplementary figure 1. Graphs reporting the modified Seborrheic Dermatitis Area Severity Index (mSDASI) scores as the estimated mean and 95%CI through 12 weeks follow-up; 1A: Estimated mean total mSDASI scores; 1B: Estimated mean erythema scores; 1C: Estimated mean desquamation scores; NSC, a non-steroidal anti-inflammatory cream * Indicates a significant difference (p < 0.05) between groups Supplementary figure 2. Percentage of subjects with different Patient Global Assessments at 4, 8, and 12 weeks; NSC, a non-steroidal anti-inflammatory cream Supplementary figure 3. Percentage changes in skin biophysics reported as the estimated mean and 95%CI through 12 weeks follow-up; 2A: Erythema index; 2B: Hydration; 2C: TEWL; 2D: Sebum levels; NSC, a non-steroidal anti-inflammatory cream; TEWL, Transepidermal water loss * Indicates a significant difference (p < 0.05) between groups Supplementary table 1. Ingredients of study products; Supplementary table 2. The results of percentage changes in skin biophysics; Supplementary table 3. Pruritus scales; Supplementary table 4. The results of clinical assessments of mSDASI scores in moderate severity